Are you also suffering the pain of being on waiting list for a kidney transplant?
Nearly 220,000 people are waiting for a kidney transplant at a given time in India, of which only 15,000 end up receiving a kidney.
Over 5 lakh people die annually whilst waiting for a transplant, despite having their name on the waiting list.
What many people do not know is that they may have a potential, suitable donor in the family who is ABO-incompatible. They may therefore not need to wait for years for a transplant, and have the possibility of receiving a kidney transplant from a family member.
ABO-incompatible kidney transplantation from a living donor can be safely performed with Glycosorb®-ABO.
There are four different ABO blood groups: A, B, AB and O.
Every person has an ABO blood group.
Our blood group is based on the presence or absence of blood group determinants on our red blood cells and tissues.
Two persons’ blood groups can be either compatible or incompatible with each other.
Over time we develop antibodies against the blood group determinants that our red blood cells and tissues do not have.
These blood group antibodies exist in our plasma and tissues.
Our bodies will recognize the blood group determinants that we do not have as “foreign”.
|A person who||This means the person|
|has blood group||has these blood group determinants||has these blood group antibodies||is ABO-compatible with blood groups||is ABO-incompatible with blood groups|
|A||A determinants||anti-B antibodies||A, O||B, AB|
|B||B determinants||anti-A antibodies||B, O||A, AB|
|AB||A & B determinants||None||All||None|
|O||None||anti-A & anti-B antibodies||O||A, B, AB|
The blood group antibodies: anti-A and anti-B antibodies.
These are only 1 % of a person’s total amount of antibodies.
YES, with GLYCOSORB®-ABO. Over 16 years of clinical experience with excellent short- and long-term results.
Glycosorb® ABO treatments before the transplant can reduce anti-A and anti-B antibodies to a safe, low enough level.
When at a safe, low enough level, it is possible to receive an ABO-incompatible kidney transplant. Standard medications for a kidney transplant are also required.
Other blood components are not affected by the treatment. This is one of the unique advantages of the Glycosorb®-ABO treatment and means that there are few, little if any side effects of the Glycosorb®-ABO treatment and also a higher efficiency of this treatment.
Glycosorb®-ABO specifically removes the cause of the ABO-incompatibility: the anti-A and anti-B antibodies in a treatment that feels similar to a dialysis treatment.
Standard medications for a kidney transplant are also required.
“The father’s anti-A antibodies can be reduced to safe levels by Glycosorb®-ABO. He can then receive a kidney from Raunak.”
“ABO-incompatible kidney transplant with Glycosorb®-ABO”